EcoDrugPlus

Adrenoceptor Beta 3a

Ensembl ID : ENSIPUG00000010110
Gene Symbol: ADRB3A
3 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSIPUG00000024151
Gene Symbol: AKR1B1.2
3 Cross references
344 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSIPUG00000005743
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-2c Adrenergic Receptor

Ensembl ID : ENSIPUG00000010180
Gene Symbol: LOC108260662
3 Cross references
157 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSIPUG00000024864
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSIPUG00000010118
Gene Symbol: AOC2
4 Cross references
411 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein A

Ensembl ID : ENSIPUG00000009697
Gene Symbol: APPA
3 Cross references
203 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSIPUG00000023561
Gene Symbol: APPB
4 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSIPUG00000016473
Gene Symbol: AR
3 Cross references
212 Possible Orthologues:

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSIPUG00000018935
Gene Symbol: LOC108268551
4 Cross references
127 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSIPUG00000002662
Gene Symbol: APLNR2
4 Cross references
171 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSIPUG00000004632
Gene Symbol: ALOX12
4 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).